TABLE OF CONTENTS
Volume 7, Issue 4 (September 2007)
SPECIAL ISSUE: New Paradigms in Life Sciences Marketing
Produced in collaboration with
INSEAD Business School and Executive Insight AG
Editorials
Editorial
Leonard Lerer
J Med Market 7: 273-274; doi:10.1057/palgrave.jmm.5050104
Business as unusual
Claus Møldrup
J Med Market 7: 275; doi:10.1057/palgrave.jmm.5050103
Session 1
Transformation planning and implementation: An evaluation of processes, experience and future directions
William Kilgallon and Rainer Lampe
J Med Market 7: 277-286; doi:10.1057/palgrave.jmm.5050111
Demographic changes in Europe: Opportunity or threat?
Julia Levy
J Med Market 7: 287-293; doi:10.1057/palgrave.jmm.5050108
The Chinese pharmaceutical market: Perspectives of the health consumer
Hu Yuanjia, Franny Geng, Bian Ying and Wang Yitao
J Med Market 7: 295-300; doi:10.1057/palgrave.jmm.5050099
Session 1 Discussion
Nick Rowell
J Med Market 7: 301-302; doi:10.1057/palgrave.jmm.5050105
Session 2
Addressing the trust issue: From share of voice to share of care
Marc Pesse
J Med Market 7: 303-307; doi:10.1057/palgrave.jmm.5050110
The reputation, image and influence of the pharmaceutical industry: Regaining credibility
Jane Parker
J Med Market 7: 309-313; doi:10.1057/palgrave.jmm.5050098
What can the pharmaceutical world learn from consumer branding practice?
Giles D Moss
J Med Market 7: 315-320; doi:10.1057/palgrave.jmm.5050102
Session 2 Discussion
Nick Rowell
J Med Market 7: 321; doi:10.1057/palgrave.jmm.5050106
Session 3
Accountability in marketing
Michel Sara
J Med Market 7: 323-331; doi:10.1057/palgrave.jmm.5050100
A model for the ex ante pricing of new drugs
Roger Turner, Christophe Lasserre and Pascal Beauchet
J Med Market 7: 333-339; doi:10.1057/palgrave.jmm.5050109
Building strong condition brands
Reinhard Angelmar, Sarah Angelmar and Liz Kane
J Med Market 7: 341-351; doi:10.1057/palgrave.jmm.5050101
